Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFragrant Prosp. Regulatory News (FPP)

Share Price Information for Fragrant Prosp. (FPP)

Share Price is delayed by 15 minutes
Get Live Data
0.415    0.00 (0.00%)
Bid:
0.40
Ask:
0.43
Spread: 0.03 (7.50%)
Market Cap: £1.06m
FPP Live PriceLast checked at - London Stock Exchange

Intraday Fragrant Prosp. Share Chart

Amendment: New CLN Issued

17 Apr 2025 08:26

RNS Number : 4491F
Fragrant Prosperity Holdings Ltd
17 April 2025
 

 

For immediate release 17 April 2025

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. 

 

Fragrant Prosperity Holdings Limited

("FPP" or the "Company")

Issue of New Convertible Loan Note

 

The below announcement replaces that issued earlier this morning to amend a typo in the date in point (i) from 31 December 2015 to 31 December 2025. Everything else in the announcement remains unaltered

 

Fragrant Prosperity Holdings Limited (the "Company"), announces it has issued convertible loan notes for £125,000 and the refinancing of existing convertible loans notes.

 

Issue of Convertible Loan Notes

 

The Company has created a new convertible loan note instruments of up to a maximum of £200,000. Notes issued under this instrument ("Notes") carry an interest rate of 5% per annum, which is to be rolled up and added to principal quarterly until the earlier of conversion or repayment of the relevant Notes. The Notes must be repaid as a bullet payment on the second anniversary of issue but Company has an option to repay the Notes at any time after the earlier of (i) 31 December 2025 and (ii) the Company has announced it has agreed the key commercial term of a reverse takeover of the Company under the UK Listing Rules.

 

Conversion of the Notes into equity becomes unconditional upon the publication of a Prospectus for a fund raise over and above the 19.99% permitted in any 12 month period without the issuance of a Prospectus. The Notes upon conversion convert into ordinary shares of the Company ("Shares") at a 10% discount to the price of a fundraise undertaken by the Company alongside the issuance of a Prospectus issued under the UK Prospectus Regulation Rules (or any successor legislation or rules). Pursuant to the subscription agreements for the Notes the Company provided a number of warranties and undertakings in respect of the Company to the investors.

 

Issue of Warrants

 

Holders of the Notes will receive 1 warrant for every share received at the placing price of the relevant Qualifying Fundraise, should the Notes automatically convert into shares upon the publication of a prospectus for a qualifying equity raise.

 

Refinancing of existing convertible loan notes

 

The Company has reached agreements with the holders of its existing convertible loan notes representing £400,000 of the total issued of £515,000 or 78% to enter into a stand still arrangement as follows:

 

· Holders agree to a stand still arrangement to preventing enforcement action until 3 September 25;

· All past accrued interest to be waived

· No applicable future interest should conversion happen prior to the end of the stand still period

· Repayment of 75% of the original principle amount advanced from the proceeds of the Note issue; and

· Automatic conversion into equity of sums owed under the loan note at the placing price upon Qualifying Fundraise of a minimum of £250,000

· Agree to a standard form lock in prohibiting the disposal of any shares received under the conversion until the earlier of 12 months from date of conversion or 6 months following the completion of a reverse take over by the Company

 

Use of proceeds

 

The Company intends to use the proceeds to repay an existing convertible loan note holder which alongside the refinancing of the remained of the existing convertible loan notes as noted above, would result in a significantly improved and recapitalised balance sheet with no other convertible loan notes in existence.

 

Related party transaction

 

Of the £125,000 Notes that have been issued, £25,000 have been subscribed for by Stonedale Management & Investments Ltd a company controlled by Simon Retter a Director of the Company.

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement this information is considered to be in the public domain.

 

ENDS

 

  

Fragrant Prosperity Holdings Limited

+44 (0) 20 3137 1902

FPP Broker: Optiva Securities Vishal Balasingham

+44 (0) 20 3137 1903

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODDDLBFEZLLBBL
Date   Source Headline
8th Mar 20237:00 amRNSHolding(s) in Company
6th Mar 20237:00 amRNSHolding(s) in Company
3rd Mar 20237:00 amRNSHolding(s) in Company
28th Feb 20233:17 pmRNSHolding(s) in Company
2nd Feb 20232:30 pmRNSHolding(s) in Company
26th Jan 20238:21 amRNSHolding(s) in Company
23rd Jan 20232:12 pmRNSHolding(s) in Company
29th Dec 20224:49 pmRNSHalf-year Report
30th Sep 20221:39 pmRNSAnnual Financial Report
3rd May 202212:55 pmRNSHolding(s) in Company
3rd May 202211:19 amRNSHolding(s) in Company
3rd May 202211:00 amRNSHolding(s) in Company
3rd May 202210:59 amRNSHolding(s) in Company
5th Apr 20222:39 pmRNSHolding(s) in Company
25th Mar 20224:22 pmRNSHolding(s) in Company
25th Mar 202212:55 pmRNSHolding(s) in Company
25th Mar 20227:00 amRNSHolding(s) in Company
24th Mar 20227:01 amRNSStmnt re Share Price Movement
24th Mar 20227:00 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSHolding(s) in Company
23rd Mar 20221:38 pmRNSHolding(s) in Company
23rd Mar 20229:05 amRNSSecond Price Monitoring Extn
23rd Mar 20229:00 amRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSHolding(s) in Company
11th Mar 20224:37 pmRNSHolding(s) in Company
9th Mar 20222:06 pmRNSSecond Price Monitoring Extn
9th Mar 20222:00 pmRNSPrice Monitoring Extension
9th Mar 20229:05 amRNSSecond Price Monitoring Extn
9th Mar 20229:00 amRNSPrice Monitoring Extension
8th Mar 20224:23 pmRNSRestoration of Listing
8th Mar 202211:55 amRNSUpdate on Intended Acquisition
1st Feb 20227:00 amRNSHalf-year Report
13th Jan 202212:21 pmRNSResult of AGM
16th Dec 20217:00 amRNSNotice of AGM
7th Dec 20212:40 pmRNSCiiTECH transaction and LR5 notification
7th Dec 20217:00 amRNSIssue of Debt
10th Nov 20212:20 pmRNSChange of Director
30th Sep 20217:00 amRNSAnnual Financial Report
29th Jul 20214:48 pmRNSRepayment & Issue of Convertible Loan Notes
6th Jul 20218:04 amRNSUpdate on Intended Acquisition
24th May 20217:35 amRNSIntended Acquisition and Suspension of Listing
24th May 20217:30 amRNSSuspension - Fragrant Prosperity Holdings Limited
16th Apr 20214:41 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
16th Apr 20212:05 pmRNSSecond Price Monitoring Extn
16th Apr 20212:00 pmRNSPrice Monitoring Extension
8th Apr 20212:05 pmRNSSecond Price Monitoring Extn
8th Apr 20212:00 pmRNSPrice Monitoring Extension
6th Apr 202111:06 amRNSSecond Price Monitoring Extn
6th Apr 202111:01 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.